Accuracy of FDA-Cleared IgE Assays in the Presence of Omalizumab (Xolair)

Accuracy of FDA-Cleared IgE Assays in the Presence of Omalizumab (Xolair)

The specimens were sent in one of two College of American Pathologists Diagnostic Allergy Surveys (SE-C-2003, SE-A-2005) to 159 CLIA-88 federally-certified American clinical laboratories which measured total IgE using the Beckman-Access; Bayer-Avida-Centaur, Dade-Behring-Nephelometer, DPC-Immulite-2...

Full description

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology Vol. 117; no. 2; p. S199
Main Author: Hamilton, R.G.
Format: Journal Article
Language:English
Published: St. Louis Mosby, Inc 01-02-2006
Elsevier Limited
Subjects:
Accuracy
Allergies
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The specimens were sent in one of two College of American Pathologists Diagnostic Allergy Surveys (SE-C-2003, SE-A-2005) to 159 CLIA-88 federally-certified American clinical laboratories which measured total IgE using the Beckman-Access; Bayer-Avida-Centaur, Dade-Behring-Nephelometer, DPC-Immulite-2000/IRMA or Pharmacia-AutoCAP/ImmunoCAP assay; multi-allergen-screen; and 5 IgE antibody specificities per serum using 11 assays from 5 manufacturers.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2005.12.786